Novartis Ag (NVS) Other Working Capital Changes (2022 - 2025)

Novartis Ag has reported Other Working Capital Changes for 18 years, with the latest figure at -$73.0 million in Q1 2026.

• Quarterly Other Working Capital Changes fell 5.8% year-over-year to -$73.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$285.0 million (up 10.38% YoY) and the FY2025 annual result came in at -$281.0 million, down 7.25% from the prior year.
• Other Working Capital Changes was little changed at -$73.0 million in Q1 2026 per NVS's latest filing, from -$73.0 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at -$59.0 million in Q2 2024 and troughed at -$126.0 million in Q4 2024.
• A 4-year average of -$309.0 million and a median of -$317.5 million in 2022 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes soared 51.24% in 2023, then sank 55.88% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$64.0 million in 2022, then changed by 0.0% to -$64.0 million in 2023, then slumped by 96.88% to -$126.0 million in 2024, then jumped by 42.06% to -$73.0 million in 2025, then changed by 0.0% to -$73.0 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$73.0 million, -$73.0 million, and -$73.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.